Skip to main content
. Author manuscript; available in PMC: 2023 Jun 14.
Published in final edited form as: Onco Ther. 2022;9(1):51–62. doi: 10.1615/OncoTherap.2022044575

TABLE 2:

NCTs in CRC utilizing curcumin

NCT Number Title Status Intervention Characteristics
NCT01333917 Curcumin Chemoprevention of Colorectal Neoplasia Completed Curcumin C3 tablet Interventional Phase 1
NCTO1490996 A Phase I/IIa Study Combining Curcumin (Curcumin C3-Complex, Sabinsa) with Standard Care FOLFOX Chemotherapy in Patients with Inoperable Colorectal Cancer Completed Curcumin C3, FOLFOX Interventional Phase 1/2
N/A Adjuvant Therapy with Bioavailability-Boosted Curcuminoids Suppresses Systemic Inflammation and Improves Quality of Life in Patients with Solid Tumors: A Randomized Double-Blind Placebo-Controlled Trial Completed Meriva (Curcumin) Double Blind Randomized Placebo Controlled
NCT00365209 Phase IIA Trial of Curcumin Among Patients with Prevalent Subclinical Neoplastic Lesions (Aberrant Crypt Foci) Completed Oral Curcumin Interventional Phase 2